Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation

Abstract

A total of 40 patients presenting with chronic myeloid leukaemia in blastic transformation were treated with a non-aggressive chemotherapy regimen consisting of vineristine, cytosine arabinoside and thioguanine. Remissions were achieved by 3/10 (30%) patients displaying lymphoid transformation (remission duration, 2, 3, and 5 months, respectively) and by 5… (More)
DOI: 10.1007/BF00685953

1 Figure or Table

Topics

  • Presentations referencing similar topics